MIR6823

Across TCGA pan-cancer cohorts, MIR6823 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR6823 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR6823 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6823 expression acts as an unfavorable survival marker.

STAD, BLCA, and ESCA are the cancer types where MIR6823 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.419	0.695	<.001	147	view →
BLCA	DFS	Tertile	All	0.205	0.622	<.001	90	view →
ESCA	OS	Tertile	II,III,IV	0.470	0.714	<.001	87	view →
KIRP	OS	Tertile	II,III,IV	0.111	0.769	<.001	72	view →
ACC	OS	Tertile	All	0.113	0.822	<.001	63	view →
LGG	DFS	Tertile	All	0.451	0.834	<.001	27	view →
KIRC	DFS	Tertile	III,IV	0.192	0.752	<.001	18	view →
UCS	OS	Tertile	All	0.153	0.687	.019	18	view →
UCEC	OS	Tertile	IV	0.308	0.748	.009	18	view →
SKCM	DFS	Tertile	III,IV	0.034	0.656	<.001	9	view →
LUSC	DFS	Tertile	All	0.357	0.715	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR6823–STAD (OS)

Open the STAD breakdown →